Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Elstein

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
American Journal of Obstetrics and Gynecology|September 26, 2006
Alfa-fetoprotein and albumin levels together are more predictive of severe fetal hydropsSorina Granovsky-Grisaru, Deborah Elstein
Immunology and Cell Biology|June 17, 2009
Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agentYaron Ilan, Deborah Elstein, Ari Zimran
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The emergence of Parkinson disease among patients with Gaucher diseaseDeborah Elstein, Roy Alcalay, Ari Zimran
Hematology (Amsterdam, Netherlands)|December 12, 2003
Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher diseaseDeborah Elstein, Gheona Altarescu, Ari Zimran
Blood Cells, Molecules & Diseases|May 3, 2006
Increased incidence of Parkinson disease among relatives of patients with Gaucher diseaseAssaf Halperin, Deborah Elstein, Ari Zimran
The Israel Medical Association Journal : IMAJ|January 7, 2015
Screening for Gaucher disease: new challengesAri Zimran, Gheona Altarescu, Deborah Elstein
The New England Journal of Medicine|February 19, 2005
The glucocerebrosidase gene and Parkinson's disease in Ashkenazi JewsAri Zimran, Orit Neudorfer, Deborah Elstein
Blood|July 25, 2006
Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher diseaseAri Zimran, Deborah Elstein, Ernest Beutler
American Journal of Hematology|February 21, 2009
Enzyme replacement therapy for mild patients with Gaucher diseaseAri Zimran, Yaron Ilan, Deborah Elstein
Blood Cells, Molecules & Diseases|June 15, 2010
Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supplyAri Zimran, Gheona Altarescu, Deborah Elstein
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
American Journal of Obstetrics and Gynecology|September 26, 2006
Alfa-fetoprotein and albumin levels together are more predictive of severe fetal hydropsSorina Granovsky-Grisaru, Deborah Elstein
Immunology and Cell Biology|June 17, 2009
Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agentYaron Ilan, Deborah Elstein, Ari Zimran
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
The emergence of Parkinson disease among patients with Gaucher diseaseDeborah Elstein, Roy Alcalay, Ari Zimran
Hematology (Amsterdam, Netherlands)|December 12, 2003
Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher diseaseDeborah Elstein, Gheona Altarescu, Ari Zimran
Blood Cells, Molecules & Diseases|May 3, 2006
Increased incidence of Parkinson disease among relatives of patients with Gaucher diseaseAssaf Halperin, Deborah Elstein, Ari Zimran
The Israel Medical Association Journal : IMAJ|January 7, 2015
Screening for Gaucher disease: new challengesAri Zimran, Gheona Altarescu, Deborah Elstein
The New England Journal of Medicine|February 19, 2005
The glucocerebrosidase gene and Parkinson's disease in Ashkenazi JewsAri Zimran, Orit Neudorfer, Deborah Elstein
Blood|July 25, 2006
Low-dose therapy trumps high-dose therapy again in the treatment of Gaucher diseaseAri Zimran, Deborah Elstein, Ernest Beutler
American Journal of Hematology|February 21, 2009
Enzyme replacement therapy for mild patients with Gaucher diseaseAri Zimran, Yaron Ilan, Deborah Elstein
Blood Cells, Molecules & Diseases|June 15, 2010
Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supplyAri Zimran, Gheona Altarescu, Deborah Elstein
Pageof 16